Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-hodgkin's lymphoma

Jane N. Winter, David J. Inwards, Stewart Spies, Gregory Wiseman, David Patton, William Erwin, Alfred W. Rademaker, Bing Bing Weitner, Stephanie F. Williams, Martin S. Tallman, Ivana Micallef, Jayesh Mehta, Seema Singhal, Andrew M. Evens, Michael Zimmer, Arturo Molina, Christine A. White, Leo I. Gordon

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences